Feng Qi, Izzi-Engbeaya Chioma N, Manousou Pinelopi, Woodward Mark
The George Institute for Global Health (UK), School of Public Health, Faculty of Medicine, Imperial College London, London, UK.
Section of Investigative Medicine and Endocrinology, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, UK.
Diabetes Obes Metab. 2025 Sep;27(9):5127-5134. doi: 10.1111/dom.16562. Epub 2025 Jun 24.
Inconsistent associations have been reported between steatotic liver disease (SLD) and depression. We aimed to investigate the cross-sectional and prospective associations between MRI-derived liver fat, SLD and depression.
We used UK Biobank data. Liver fat was measured with liver MRI proton density fat fraction. SLD was defined as liver fat ≥5%. Depression was identified through self-reported diagnosis and hospital records. We examined cross-sectional associations using logistic regression and prospective associations using Cox proportional hazards models, adjusting for potential confounders, including socioeconomic status, lifestyle factors and body mass index (BMI).
Participants numbering 36 587 were included (age 64.5 years, 51.4% females, 28.2% SLD), and of these, 2849 participants had prevalent depression, higher in individuals with SLD (9.1%) than in those without (7.3%). SLD was associated with 40% higher odds of depression (OR: 1.40 (1.29, 1.52)) after adjusting for age, sex and socioeconomic status, but this was attenuated (OR: 1.12 (1.01, 1.23)) after adjusting for BMI. In the prospective analysis (n = 33 762), 414 people received a new diagnosis of depression over a median follow-up of 4.5 years. SLD was initially associated with a 27% higher depression risk (HR: 1.27 [1.03, 1.56]), but this was no longer significant after BMI adjustment (HR: 0.93 (0.73, 1.18)). Liver fat (per 5% increase) was not associated with depression risk (HR: 1.02 (0.92, 1.12)). No sex differences were identified.
The association between liver fat and depression is likely due to reverse causation and the confounding effect of BMI.
关于脂肪性肝病(SLD)与抑郁症之间的关联报道并不一致。我们旨在研究磁共振成像(MRI)衍生的肝脏脂肪、SLD与抑郁症之间的横断面和前瞻性关联。
我们使用了英国生物银行的数据。通过肝脏MRI质子密度脂肪分数测量肝脏脂肪。SLD定义为肝脏脂肪≥5%。通过自我报告诊断和医院记录确定抑郁症。我们使用逻辑回归检验横断面关联,使用Cox比例风险模型检验前瞻性关联,并对潜在混杂因素进行调整,包括社会经济地位、生活方式因素和体重指数(BMI)。
纳入了36587名参与者(年龄64.5岁,51.4%为女性,28.2%患有SLD),其中2849名参与者患有抑郁症,患有SLD的个体中抑郁症患病率(9.1%)高于未患SLD的个体(7.3%)。在调整年龄、性别和社会经济地位后,SLD与抑郁症的患病几率高40%相关(比值比:1.40(1.29,1.52)),但在调整BMI后这种关联减弱(比值比:1.12(1.01,1.23))。在前瞻性分析(n = 33762)中,在中位随访4.5年期间,414人被新诊断为抑郁症。SLD最初与抑郁症风险高27%相关(风险比:1.27 [1.03,1.56]),但在调整BMI后不再显著(风险比:0.93(0.73,1.18))。肝脏脂肪(每增加5%)与抑郁症风险无关(风险比:1.02(0.92,1.12))。未发现性别差异。
肝脏脂肪与抑郁症之间的关联可能是由于反向因果关系和BMI的混杂效应。